Skip to main content

Advertisement

Table 5 Change in grip strength (kg) and pressure pain threshold from baseline to 5 week neuromuscular taping therapy

From: Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial

Measure Groups
Experimental Control
Mean (CI 95%) F(p) Mean (CI 95%) F(p)
HG Healthy Hand   0.80 (0.54)   0.11 (0.98)
 Basal (T1) 16.45 (13.68–19.21)   18.70 (16.61–20.78)  
 After 1st NMT (T1) 16.70 (14.13–19.26)   18.32 (16.35–20.29)  
 Arrival 1st week (T2) 17.31 (14.57–20.05)   17.90 (15.82–19.98)  
 After 2nd NMT (T2) 17.65 (15.12–20.17)   18.20 (16.09–20.30)  
 Arrival 5nd week (T3) 19.07 (16.26–21.88)   18.80 (16.79–20.80)  
 After 3rd NMT (T3) 19.12 (16.44–21.80)   18.45 (16.34–20.55)  
HG Affected Hand   0.49 (0.77)   0.18 (0.96)
 Basal (T1) 14.16 (10.99–17.33)   16.85 (14.58–19.11)  
 After 1st NMT (T1) 13.88 (11.24–16.53)   16.30 (14.09–18.50)  
 Arrival 1st week (T2) 15.18 (12.43–17.93)   16.65 (14.35–18.94)  
 After 2nd NMT (T2) 15.12 (12.55–17.69)   16.27 (14.03–18.51)
 Arrival 5nd week (T3) 15.87 (13.23–18.51)   17.50 (15.24–19.75)  
 After 3rd NMT (T3) 16.27 (13.50–19.04)   16.57 (14.50–18.64)  
Cervical PPT   0.35 (0.88)   0.44 (0.81)
 Basal (T1) 11.96 (10.12–13.80)   12.31 (10.63–13.99)  
 After 1st NMT (T1) 12.37 (10.50–14.23)   11.80 (10.13–13.46)  
 Arrival 1st week (T2) 10.93 (9.24–12.62)   12.08 (10.52–13.63)  
 After 2nd NMT (T2) 11.35 (9.69–13.01)   11.07 (9.47–12.66)  
 Arrival 5nd week (T3) 11.73 (9.74–13.71)   11.47 (10.05–12.88)  
 After 3rd NMT (T3) 11.34 (9.56–13.12)   11.13 (9.55–12.71)  
Lumbar PPT   0.08 (0.99)   0.23 (0.94)
 Basal (T1) 13.76 (11.52–16.00)   15.43 (13.35–17.50)  
 After 1st NMT (T1) 14.38 (12.20–16.56)   14.50 (12.63–16.37)  
 Arrival 1st week (T2) 14.05 (12.06–16.04)   15.06 (12.61–17.51)  
 After 2nd NMT (T2) 14.49 (12.46–16.52)   14.25 (12.04–16.45)  
 Arrival 5nd week (T3) 14.05 (12.07–16.02)   15.35 (13.54–17.16)  
 After 3rd NMT (T3) 14.45 (12.56–16.34)   15.12 (13.25–16.99)  
Median Nerve PPT   0.46 (0.80)   0.42 (0.83)
 Basal (T1) 18.74 (16.27–21.21)   17.99 (15.97–20.01)  
 After 1st NMT (T1) 18.45 (16.02–20.87)   17.19 (15.34–19.04)  
 Arrival 1st week (T2) 17.53 (15.76–19.29)   17.51 (15.73–19.28)  
 After 2nd NMT (T2) 17.43 (15.53–19.32)   16.88 (14.98–18.77)  
 Arrival 5nd week (T3) 17.16 (15.19–19.13)   16.76 (14.84–18.68)  
 After 3rd NMT (T3) 17.14 (15.17–19.10)   16.32 (14.43–18.21)  
Tibialis Anterior PPT   0.22 (0.95)   0.80 (0.55)
 Basal (T1) 15.39 (13.41–17.37)   17.29 (15.49–19.08)  
 After 1st NMT (T1) 15.51 (13.53–17.48)   17.10 (15.35–18.84)  
 Arrival 1st week (T2) 15.02 (13.14–16.89)   16.65 (14.87–18.43)  
 After 2nd NMT (T2) 14.86 (12.89–16.82)   16.16 (14.17–18.14)  
 Arrival 5nd week (T3) 14.56 (12.74–16.38)   15.71 (14.04–17.38)  
 After 3rd NMT (T3) 14.46 (12.70–16.21)   15.39 (13.69–17.08)  
  1. Abbreviations: HG Hand Grip, PPT Pressure Pain Threshold, NMT Neuromuscular Taping. T1 (Baseline). T2 (1 week after) and T3 (5 week after)